Long-term outcomes of endoscopic ultrasound-guided laser ablation for liver tumors in the caudate lobe: 5 years of experience

References

• Takayama T, Midorikawa Y, Higaki T, et al. Algorithm for resecting hepatocellular carcinoma in the caudate lobe. Ann Surg. 2021;273(6):e222–e229.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Shimada M, Shirabe K, et al. Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe. Am J Surg. 2005;190(3):451–455.
   PubMed Web of Science ®Google Scholar
• Miyayama S, Yamashiro M, Yoshie Y, et al. Hepatocellular carcinoma in the caudate lobe of the liver: variations of its feeding branches on arteriography. Jpn J Radiol. 2010;28(8):555–562.
   PubMed Web of Science ®Google Scholar
• Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3(5):3: 317–325.
   PubMed Web of Science ®Google Scholar
• Di Costanzo GG, Tortora R, D'Adamo G, et al. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial. J Gastroenterol Hepatol. 2015;30(3):559–565.
   PubMed Web of Science ®Google Scholar
• Francica G, Petrolati A, Di Stasio E, et al. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location. Am J Roentgenol. 2012;199(6):1393–1401.
   PubMed Web of Science ®Google Scholar
• Hyun D, Cho SK, Shin SW, et al. Treatment of small hepatocellular carcinoma (</=2 cm) in the caudate lobe with sequential transcatheter arterial chemoembolization and radiofrequency ablation. Cardiovasc Intervent Radiol. 2016;39(7):1015–1022.
   PubMed Web of Science ®Google Scholar
• Zhang X, He X, Zeng Q, et al. Utility of fusion imaging for percutaneous thermal ablation of hepatocellular carcinoma in the caudate lobe. J Vasc Interv Radiol. 2021;32(8):1209–1214.
   PubMed Web of Science ®Google Scholar
• Braden B, Gupta V, Dietrich CF. Therapeutic EUS: new tools, new devices, new applications. Endosc Ultrasound. 2019;8(6):370–381.
   PubMed Web of Science ®Google Scholar
• Di Matteo FM, Saccomandi P, Martino M, et al. Feasibility of EUS-guided Nd: YAG laser ablation of unresectable pancreatic adenocarcinoma. Gastrointest Endosc. 2018;88(1):168–174.e1.
   PubMed Web of Science ®Google Scholar
• Jiang T, Chai W. Endoscopic ultrasonography (EUS)-guided laser ablation (LA) of adrenal metastasis from pancreatic adenocarcinoma. Lasers Med Sci. 2018;33(7):1613–1616.
   PubMed Web of Science ®Google Scholar
• Attili F, Boskoski I, Bove V, et al. EUS-guided radiofrequency ablation of a hepatocellular carcinoma of the liver. VideoGIE. 2018;3(5):149–150.
   PubMedGoogle Scholar
• Chai W, Zhao Q, Song H, et al. Treatment response and preliminary efficacy of hepatic tumour laser ablation under the guidance of percutaneous and endoscopic ultrasonography. World J Surg Oncol. 2019;17(1):133.
   PubMed Web of Science ®Google Scholar
• Jiang T, Tian G, Bao H, et al. EUS dating with laser ablation against the caudate lobe or left liver tumors: a win-win proposition? Cancer Biol Ther. 2018;19(3):145–152.
   PubMed Web of Science ®Google Scholar
• Pacella CM, Bizzarri G, Magnolfi F, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology. 2001;221(3):712–720.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Filippiadis DK, Binkert C, Pellerin O, et al. CIRSE quality assurance document and standards for classification of complications: the CIRSE classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–1146.
   PubMed Web of Science ®Google Scholar
• Yan Y, Lin ZY, Chen J. Analysis of imaging-guided thermal ablation puncture routes for tumors of the hepatic caudate lobe. J Cancer Res Ther. 2020;16(2):258–262.
   PubMed Web of Science ®Google Scholar
• Liu B, Long J, Wang W, et al. Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study. BMC Cancer. 2019;19(1):699.
   PubMed Web of Science ®Google Scholar
• Chua T, Faigel DO. Endoscopic ultrasound-guided ablation of liver tumors. Gastrointest Endosc Clin N Am. 2019;29(2):369–379.
   PubMedGoogle Scholar
• Nakaji S, Hirata N, Mikata R, et al. Clinical outcomes of endoscopic ultrasound-guided ethanol injection for hepatocellular carcinoma in the caudate lobe. Endosc Int Open. 2016;4(10):E1111–E1115.
   PubMedGoogle Scholar
• Di Matteo F, Grasso R, Pacella CM, et al. EUS-guided Nd: YAG laser ablation of a hepatocellular carcinoma in the caudate lobe. Gastrointest Endosc. 2011;73(3):632–636.
   PubMed Web of Science ®Google Scholar
• Carrara S, Arcidiacono PG, Albarello L, et al. Endoscopic ultrasound-guided application of a new internally gas-cooled radiofrequency ablation probe in the liver and spleen of an animal model: a preliminary study. Endoscopy. 2008;40(9):759–763.
   PubMed Web of Science ®Google Scholar
• Li T, Khokhlova T, Maloney E, et al. Endoscopic high-intensity focused US: technical aspects and studies in an in vivo porcine model (with video). Gastrointest Endosc. 2015;81(5):1243–1250.
   PubMed Web of Science ®Google Scholar
• Kang TW, Lim HK, Lee MW, et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology. 2016;280(1):300–312.
   PubMed Web of Science ®Google Scholar
• Germani G, Gurusamy K, Garcovich M, et al. Which matters most: number of tumors, size of the largest tumor, or total tumor volume? Liver Transpl. 2011;17(Suppl 2):S58–S66.
   PubMed Web of Science ®Google Scholar
• Toro A, Ardiri A, Mannino M, et al. Effect of pre- and post-treatment alpha-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study. BMC Surg. 2014;14:40.
   PubMed Web of Science ®Google Scholar
• Pacella CM, Bizzarri G, Francica G, et al. Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablation. J Hepatol. 2006;44(5):902–909.
   PubMed Web of Science ®Google Scholar
• Philips P, Farmer RW, Scoggins CR, et al. Caudate lobe resections: a single-center experience and evaluation of factors predictive of outcomes. World J Surg Oncol. 2013;11:220.
   PubMed Web of Science ®Google Scholar
• Kim HC, Miyayama S, Chung JW. Selective chemoembolization of caudate lobe hepatocellular carcinoma: anatomy and procedural techniques. Radiographics. 2019;39(1):289–302.
   PubMed Web of Science ®Google Scholar